ArticleFrontiers in molecular biosciences2025
Decoding the exosomal nucleic acid delivery system axis of macrophage autophagy and immune reprogramming via multi-omics analysis.
Article in Frontiers in molecular biosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bioinformatics and experimental analysis identify CHN2 and MEF2C as diagnostic biomarkers for tuberculosis.American journal of translational research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: MicroRNA-155 (miR-155) is a key regulator of macrophage function, and its abnormal expression is closely associated with the pathogenesis of tuberculosis (TB)-a disease where impaired macrophage autophagy weakens anti-mycobacterial immunity. Exosomes are promising nucleic acid carriers due to their biocompatibility and cell-targeting ability. Here, we constructed exosome-based miR-155 delivery systems (Exo-miR155-ago/Exo-miR155-antago; "ago" = agomir, a miR-155 agonist that enhances its expression; "antago" = antagomir, a miR-155 antagonist that inhibits its expression) to modulate macrophage autophagy and remold anti-TB immune responses. Methods: Exosomes were isolated from the supernatant of bone marrow mesenchymal stem cells using differential centrifugation. The miR155-5p agomir and antagomir were transfected into exosomes via the Exosome Transfection Kit, followed by co-incubation with macrophages. Transcriptomics and proteomics were employed to screen for differentially expressed genes and proteins. Western blot was employed to detect autophagy-related proteins and phosphorylated proteins in signaling pathways (p- denotes phosphorylation, a key post-translational modification regulating protein activity). Techniques including transmission electron microscopy (TEM), Monodansylcadaverine (MDC) staining, and reverse transcription-quantitative polymerase chain reaction (RT-qPCR) were applied to detect the autophagic level of macrophages. Results: Transcriptome sequencing identified 704 differentially expressed genes, with significant enrichment in TNF and NF-κB pathways, differential expression of NF-κB target genes (e.g., autophagy core gene Beclin1), and expression changes in key genes of the energy metabolism-related AMPK/mTOR pathway; proteomic analysis found 164 differentially expressed proteins, including key molecules of the "Pathogen Recognition-TLR4-NF-κB-Autophagy-Related Gene Transcription" pathway (TLR4, p-p65) and core proteins of the AMPK/mTOR pathway (p-AMPK, p-mTOR); functional verification showed the Exo-miR155-ago group had more autophagosomes (TEM), higher autophagic vacuole accumulation (MDC staining), upregulated mRNA/protein of autophagy-related molecules (LC3B, Beclin1), downregulated mRNA/protein of p62 (RT-qPCR/Western blot), activated p-p65 (NF-κB pathway), and increased p-AMPK with decreased p-mTOR (AMPK/mTOR pathway), and all results confirmed Exo-miR155-ago promotes macrophage autophagy via the synergistic effect of the two pathways. Conclusion: This study provides multi-omics evidence for autophagy modulation mediated by the exosomal nucleic acid delivery system, verifies that this system regulates macrophage autophagy by controlling the TLR4-NF-κB pathway and AMPK/mTOR pathway, and clarifies the application potential of this system in tuberculosis (TB) and other macrophage-associated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.